forphenicinol has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nitta, K; Tanaka, T | 1 |
| Nitta, K; Takeuchi, M; Tanaka, T | 1 |
2 other study(ies) available for forphenicinol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Enhancement of immune response by an antitumor agent, cyclophosphamide].
Topics: Animals; Cell Line; Cyclophosphamide; Female; Fibrosarcoma; Glycine; Immunity, Cellular; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; T-Lymphocytes, Regulatory | 1986 |
Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Cell Division; Combined Modality Therapy; Cyclophosphamide; Female; Glycine; Immunity, Innate; Immunization; Leukemia L1210; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Isogeneic | 1985 |